AU2002348020A1 - Tyrosine kinase inhibitors - Google Patents

Tyrosine kinase inhibitors

Info

Publication number: AU2002348020A1
Authority: AU; Australia
Prior art keywords: tyrosine kinase; kinase inhibitors; inhibitors; tyrosine; kinase
Prior art date: 2001-10-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002348020A

Inventor

Ian M. Bell

B. Wesley Trotter

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck and Co Inc

Original Assignee

Merck and Co Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-25

Filing date

2002-10-21

Publication date

2003-05-06

2002-10-21 Application filed by Merck and Co Inc filed Critical Merck and Co Inc

2003-05-06 Publication of AU2002348020A1 publication Critical patent/AU2002348020A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AU2002348020A 2001-10-25 2002-10-21 Tyrosine kinase inhibitors Abandoned AU2002348020A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US34290001P	2001-10-25	2001-10-25
US60/342,900		2001-10-25
PCT/US2002/033921 WO2003035616A2 (en)	2001-10-25	2002-10-21	Tyrosine kinase inhibitors

Publications (1)

Publication Number	Publication Date
AU2002348020A1 true AU2002348020A1 (en)	2003-05-06

Family

ID=23343769

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002348020A Abandoned AU2002348020A1 (en)	2001-10-25	2002-10-21	Tyrosine kinase inhibitors

Country Status (2)

Country	Link
AU (1)	AU2002348020A1 (en)
WO (1)	WO2003035616A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1651209A4 (en) *	2003-07-24	2009-03-04	Merck & Co Inc	TYROSINE KINASE INHIBITORS
DK1926996T3 (en)	2005-09-20	2012-01-23	Osi Pharmaceuticals Llc	Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
EP2400985A2 (en)	2009-02-25	2012-01-04	OSI Pharmaceuticals, LLC	Combination of an either an anti-igf-1r antibody or an igf binding protein and a small molecule igf-1r kinase inhibitor
EP2400990A2 (en)	2009-02-26	2012-01-04	OSI Pharmaceuticals, LLC	In situ methods for monitoring the emt status of tumor cells in vivo
WO2010099138A2 (en)	2009-02-27	2010-09-02	Osi Pharmaceuticals, Inc.	Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
WO2010099363A1 (en)	2009-02-27	2010-09-02	Osi Pharmaceuticals, Inc.	Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
US8465912B2 (en)	2009-02-27	2013-06-18	OSI Pharmaceuticals, LLC	Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
WO2010146059A2 (en)	2009-06-16	2010-12-23	F. Hoffmann-La Roche Ag	Biomarkers for igf-1r inhibitor therapy
US20110275644A1 (en)	2010-03-03	2011-11-10	Buck Elizabeth A	Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
CA2783665A1 (en)	2010-03-03	2011-09-09	OSI Pharmaceuticals, LLC	Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
WO2011112666A1 (en)	2010-03-09	2011-09-15	OSI Pharmaceuticals, LLC	Combination anti-cancer therapy
US20120214830A1 (en)	2011-02-22	2012-08-23	OSI Pharmaceuticals, LLC	Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors in hepatocellular carcinoma
WO2012149014A1 (en)	2011-04-25	2012-11-01	OSI Pharmaceuticals, LLC	Use of emt gene signatures in cancer drug discovery, diagnostics, and treatment
WO2013152252A1 (en)	2012-04-06	2013-10-10	OSI Pharmaceuticals, LLC	Combination anti-cancer therapy
WO2014134202A1 (en)	2013-02-26	2014-09-04	Triact Therapeutics, Inc.	Cancer therapy
CA2923667A1 (en)	2013-09-09	2015-03-12	Triact Therapeutics, Inc.	Cancer therapy
CN104961669B (en) *	2015-03-18	2018-02-13	河南农业大学	The preparation method of the pyrrole carboxylic acid ester of 2 methyl of N alkyl, 5 formoxyl 3 and its application in perfuming cigarette
US11161823B2 (en)	2019-03-11	2021-11-02	National Guard Health Affairs	Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1139754A4 (en) *	1998-12-31	2002-12-18	Sugen Inc	3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy

2002
- 2002-10-21 WO PCT/US2002/033921 patent/WO2003035616A2/en not_active Ceased
- 2002-10-21 AU AU2002348020A patent/AU2002348020A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2003035616A2 (en)	2003-05-01
WO2003035616A3 (en)	2003-10-23

Publication	Publication Date	Title
AU2002361577A1 (en)	2003-05-12	Tyrosine kinase inhibitors
AU2002334355A1 (en)	2003-03-18	Protein tyrosine kinase inhibitors
AU2003299651A1 (en)	2004-06-30	Tyrosine kinase inhibitors
EP1381598A4 (en)	2008-03-19	Novel tyrosine kinase inhibitors
AU2003298942A1 (en)	2004-06-30	Tyrosine kinase inhibitors
AU2001237041A1 (en)	2001-11-08	Kinase inhibitors
AU2003282891A1 (en)	2004-04-23	Novel tyrosine kinases inhibitors
AU2000240570A1 (en)	2001-10-08	Pyrrolopyrimidines as tyrosine kinase inhibitors
AU2002305260A1 (en)	2002-11-11	Pyrazole derived kinase inhibitors
AU2002348394A1 (en)	2003-05-06	Tyrosine kinase inhibitors
AU2437900A (en)	2000-08-07	Piperidinylquinolines as protein tyrosine kinase inhibitors
AU2003275282A1 (en)	2004-04-23	Novel tyrosine kinase inhibitors
AU2002357193A1 (en)	2003-07-09	Thienopyrimidine compounds as protein tyrosine kinase inhibitors
AU2002348020A1 (en)	2003-05-06	Tyrosine kinase inhibitors
AU2002348393A1 (en)	2003-05-06	Tyrosine kinase inhibitors
AU2002323406A1 (en)	2003-03-18	Tyrosine kinase inhibitors
AU2001241917A1 (en)	2001-09-12	Myt1 kinase inhibitors
AU2002327534A1 (en)	2003-03-03	Tyrosine kinase inhibitors
AU2002253350A1 (en)	2002-11-11	4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors
AU2002326758A1 (en)	2003-03-03	Tyrosine kinase inhibitors
AU2002326760A1 (en)	2003-03-18	Tyrosine kinase inhibitors
AU2002355733A1 (en)	2003-02-17	Tyrosine kinase inhibitors
AU2002304001A1 (en)	2003-01-02	Tyrosine kinase inhibitors
AU2002326865A1 (en)	2003-04-01	Tyrosine kinase inhibitors
AU2002327342A1 (en)	2003-02-17	Tyrosine kinase inhibitors

Legal Events

Date	Code	Title	Description
2004-07-15	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase